The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Lipitor® 10mg chewable tablets (SSP032). SSP032 for Lipitor® 10mg chewable tablets was due to expire on 26 August 2022 but the end date has been further extended to Friday 2 September 2022.

SSP032 – Lipitor® 10mg chewable tablets

SSP032 provides that for every Lipitor® 10mg chewable tablet originally prescribed, either one Atorvastatin 10mg film-coated tablet or the equivalent dose of Atorvastatin 20mg/5ml oral suspension sugar free must be supplied.

For prescriptions (NHS or private) requesting:
Supply permitted under SSP032:
Current expiry date
Lipitor® 10mg chewable tablets
Atorvastatin 10mg tablets
Atorvastatin 20mg/5ml oral suspension sugar free
This SSP has been varied – the revised end date for SSP032 is now Friday 2 September 2022

Please note: expiry dates of an SSP may be brought forward or extended, and the content may be amended at any time during the life of an SSP. Pharmacists should ensure they are using the latest version of an SSP before considering the supply of an alternative product.

Current versions of SSPs can be found at:

Support in implementing the SSPs

The following resources have been developed to support pharmacy teams in using these protocols.

Current versions of SSPs

Serious Shortage Protocols Operational Guidance

Serious Shortage Protocols Questions & Answers

PSNC’s Serious Shortage Protocols (SSPs) Endorsing Factsheet

PSNC Briefing 023/19: Serious Shortage Protocols – A guide for community pharmacy teams

Background information on SSPs

Further information on what SSPs are and when they may be used is available via the links below.

Serious Shortage Protocols (SSPs) on-demand webinar

Serious Shortage Protocols (SSPs) webpage

The post SSP for Lipitor® 10mg chewable tablets extended appeared first on PSNC Website.